John Trizzino, EVP, Chief Commercial Officer at NOVAVAX INC (NVAX), sold 4,946 shares at $292.91 ($1.4M) on 2021-02-05, disclosed to the SEC on 2021-02-09.
Seasonal sale ($1.4M) by EVP, Chief Commercial Officer — this insider has traded NVAX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $282.00 | 19 | $5K | 0.4% |
| 2 | $283.50 | 1,020 | $289K | 20.0% |
| 3 | $284.82 | 25 | $7K | 0.5% |
| 4 | $287.03 | 30 | $9K | 0.6% |
| 5 | $289.45 | 55 | $16K | 1.1% |
| 6 | $290.18 | 8 |
| $2K |
| 0.2% |
| 7 | $290.18 | 182 | $53K | 3.6% |
| 8 | $290.86 | 57 | $17K | 1.1% |
| 9 | $291.79 | 117 | $34K | 2.4% |
| 10 | $292.91 | 272 | $80K | 5.5% |
| 11 | $292.91 | 272 | $80K | 5.5% |
| 12 | $293.96 | 405 | $119K | 8.2% |
| 13 | $293.96 | 405 | $119K | 8.2% |
| 14 | $295.05 | 625 | $184K | 12.7% |
| 15 | $295.05 | 625 | $184K | 12.7% |
| 16 | $296.01 | 238 | $70K | 4.9% |
| 17 | $296.01 | 238 | $70K | 4.9% |
| 18 | $296.96 | 104 | $31K | 2.1% |
| 19 | $297.82 | 30 | $9K | 0.6% |
| 20 | $298.80 | 25 | $7K | 0.5% |
| 21 | $324.50 | 194 | $63K | 4.3% |
| Total | $293.05 avg | 4,946 | $1.4M | 100% |
| Filing → |
| NVAX | SELL | 2021-09-22 | $6.8M | — | Filing → |
| NVAX | SELL | 2021-09-15 | $7.0M | — | Filing → |
| NVAX | SELL | 2021-05-07 | $802K | — | Filing → |